T-28 Impact of insulin resistance on virologic response to a telaprevir-based regimen in patients with HCV genotype 1 and prior peginterferon/ribavirin treatment failure: post-hoc analysis of the REALIZE Phase III study
Title:
T-28 Impact of insulin resistance on virologic response to a telaprevir-based regimen in patients with HCV genotype 1 and prior peginterferon/ribavirin treatment failure: post-hoc analysis of the REALIZE Phase III study
Author:
Andreone, P. Younossi, Z. Negro, F. Serfaty, L. Pol, S. Diago, M. Zeuzem, S. Lawitz, E.J. Roberts, S. Focaccia, R. Foster, G.R. Horban, A. Lonjon-Domanec, I. Coate, B. DeMasi, R. Picchio, G. Witek, J.